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ABSTRACT 
Background 
Overweight and obesity have significant impact and consequences on women leading 
to reduced quality of life, comorbid conditions and premature mortality. Many 
healthcare providers lack adequate training and the time to properly treat overweight 
and obesity. Algorithms have been shown to improve clinical knowledge and save 
time. 
Objectives 
To develop an algorithm for weight loss assessment and treatment to aid in the 
clinical decision-making process while improving the quality of care for overweight 
and obese clients in an efficient manner that can be replicated. 
Methods 
After an extensive literature review to identify best-practice guidelines for weight loss 
a retrospective chart review was performed at two women’s health clinics located in 
St. Louis County over a five-month period. For three consecutive appointments 50 
patient charts were audited and compared to current evidence-based practice 
guidelines. Any gaps between the office practice and the guidelines were identified. A 
weight loss algorithm was then developed incorporating clinical assessment methods, 
lab work, anthropometric measurements and appropriate referrals.  
Results 
Fifty patient’s charts spanning from 10/2014-01/2017 were examined and compared 
to evidence-based clinical guidelines for weight loss. The comparison revealed gaps 
between evidence based research and practice related to lack of time, not wanting to 
add additional work for the staff/ healthcare providers, and forgetting to include 
various assessments and referrals. To improve the assessment practice while saving 
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valuable clinical time, an algorithm was recommended as a template to use in the 
electronic health records (EHR) along with a hard-copy paper form. Additional 
measurements were added to the women’s health clinic computer system for neck and 
waist circumference by their IT staff, and a packet was developed containing 
assessment questionnaires for patients to either complete prior to coming to the initial 
appointment or fill out while in the waiting room. This weight loss algorithm was 
then presented to the participating clinician for implementation for a future pilot 
study. 
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Introduction 
 The objective of this clinical scholarship project is to examine evidence-based 
algorithms for weight loss and obesity, compare them to current practice in a 
women’s health clinic based near St. Louis, Missouri and to develop a functional/ 
duplicable algorithm which would guide clinical decision-making to treat overweight 
and obesity in women. This algorithm will help standardize treatments for clinicians 
and encourage women to be the most successful at losing weight, thus decreasing the 
incidence of mortality and morbidity related to obesity. Properly and consistently 
treating overweight and obesity will help reduce cardiovascular disease, type 2 
diabetes, certain cancers, osteoarthritis, infertility, as well as other medical conditions 
in this population (National Heart, Lung, and Blood Institute, 2012). 
Background 
 Obesity is now one of the most visible, but neglected public health problems 
globally. According to the World Health Organization (WHO, 2014), the prevalence 
of obesity globally has more than doubled between 1980 and 2014. Around the world, 
there are now over 1.9 billion overweight adults and of these 600 million are obese 
(WHO, 2014). The United States, a country that accounts for only 5% of the world’s 
population, comprises 13% of those who are overweight and obese (Murray, Ng, & 
Mokdad, 2013). Approximately two thirds of American women are overweight or 
obese, while 9.9% are extremely obese (Centers for Disease Control and Prevention 
[CDC], 2015; Flegal, Kruszon-Moran, Carroll, Fryar, & Ogden, 2016). In the state of 
Missouri, just over 59% of women are overweight (CDC, 2014), while women 
residing in the city of St. Louis fall closely behind this statistic at 58.8% (Department 
of Health, City of St. Louis, 2015).  
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 The increasing prevalence of obesity predicts rising financial burden from 
associated comorbidities, especially cardiovascular disease, diabetes and cancer 
(Wang, McPherson, Marsh, Gortmaker, & Brown, 2011). These trends are expected 
to continue in the United States, estimating 65 million more obese adults by 2030. 
Medical costs to treat obesity and its related diseases are expected to increase $48-66 
billion per year for this same period (Wang et al., 2011). Another study by Schmier, 
Jones and Halpern (2006), analyzed insurance claims data and discovered overweight 
and obese employees had consistently higher work-related costs, such as; sick leave, 
disability and workplace injuries. 
 Obesity leads to serious health consequences, including increased risk of 
premature death to comorbid conditions that reduce the general quality of life. 
Overweight and obesity directly and indirectly affects women. Cardiovascular disease 
is the number one obesity-related cause of mortality of women and one in four 
women will die from heart disease (Xu, Murphy, Kochanek, & Bastian, 2016). While 
coronary heart disease (CHD) is the number one killer for both men and women in 
the United States, coronary microvascular disease and broken heart syndrome (stress-
induced cardiomyopathy) target more women (National Heart, Lung and Blood 
Institute, 2014). Nearly 64% (two-thirds) of women who die suddenly from CHD 
have no prior symptoms (American Heart Association, 2012). 
 Certain cancers such as ovarian, cervical and breast all have a higher 
incidence in overweight or obese women (Kulie et al., 2011). The duration of how 
long a woman has been overweight has been shown to impact the risk of developing 
these cancers, including endometrial (Arnold et al., 2016). Renehan, Tyson, Egger, 
Heller and Zwahlen (2008) go on to include an association between a higher body 
mass index (BMI) and gallbladder, esophageal adenomas and renal cancers in 
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overweight or obese women. A weaker link was noted in women for pancreatic, 
postmenopausal breast, thyroid and colon cancers, while leukemia, multiple myeloma 
and non-Hodgkin’s lymphoma affect both men and women (Renehan, Tyson, Egger, 
Heller, & Zwahlen, 2008).  
 An overweight or obese woman is also more likely to develop metabolic 
syndrome, type 2 diabetes or have problems with infertility related to polycystic 
ovarian syndrome (PCOS) (Hu, 2003). Obesity contributes to various reproductive 
disorders such as anovulation, menstrual issues, infertility, miscarriage, difficulties 
with assisted reproduction and adverse pregnancy outcomes (Dag & Dilbaz, 2015; 
Jungheim, Travieso, & Hopeman, 2013). There is also an association with decreased 
intention, initiation and duration of breastfeeding in mothers who are obese (Kulie et 
al., 2011). 
 Overweight and obesity in pregnancy not only increases health risks for the 
woman, but also for her child. This is due to a higher incidence of preterm birth 
associated with this condition (Cnattingius et al., 2013; McDonald, Han, Mulla, & 
Beyene, 2010). Research also links obesity to an increase in preterm birth, to 
childhood and adult obesity, cardiovascular disease, and type 2 diabetes (Leddy, 
Power, & Schulkin, 2008). Nearly one in four (23.4%) women are obese prior to 
becoming pregnant (Osterman et al., 2013). A pregnant woman's preconception 
weight can influence the child’s health (Beil, 2016; Patel, Pasupathy, & Poston, 
2015). If she has a higher body mass index (BMI) prior to becoming pregnant it may 
be a determinant in her child’s risk for cardiometabolic disorders later in adulthood, 
thus perpetuating the obesity cycle for future generations (Beil, 2016; Patel et al., 
2015). 
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 The psychological effects of being overweight or obese are especially difficult 
for most women. There are social and cultural implications involved as well (Carlson 
& Seacat, 2014). The stigma towards obese women can lead to low self-esteem and 
depression (Kulie et al., 2011). A woman experiencing weight-stigma is increasingly 
vulnerable to not only depression and esteem issues but to a poor body image, 
exercise avoidance and maladaptive eating behaviors (National Obesity Observatory 
[NOO], 2011). The NOO (2011) goes on to state there is a bi-directional relationship 
between obesity and mental health issues, with various levels of obesity, gender, age 
and socioeconomic status being contributing risk factors.  
Obstacles 
 Many obstacles can be attributed to why obesity counseling and treatments are 
not adequately being done. Lewis and Gudzune (2014) stated the lack of provider 
training, time, reimbursement and provider weight-bias as obstacles. According to 
Forman-Hoffman, Little, and Wahls (2006) many primary care health care providers 
(HCP) do not have adequate training in obesity treatments and are often unaware of 
facility options for weight loss. Many clinicians believe the patient’s weight is related 
to a lack of will power and is their own fault. Proper seating, exam tables, large blood 
pressure cuffs, gowns, etcetera are not always available to accommodate these 
patients (National Institute of Diabetes and Digestive and Kidney Diseases, 2011). 
 The patient-related barriers for weight loss and obesity treatments include feeling 
embarrassed and facing disrespectful comments about their weight by the HCP or 
staff. In a qualitative study by Metzgar, Preston, Miller, and Nickols-Richardson 
(2015) further patient barriers included: life transitions, internal and environmental 
pressures, health status changes, lack of accountability and social support.  
Review of the Literature 
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 The review of literature included databases from: Medline (EBSCO), 1946-
Present, Medline (OVID), 1946-Present, Google Scholar and Science Direct. Key 
words: Adiposity, Barriers, Obesity algorithms, Overweight and obesity practices, 
Primary care treatment for obesity, Weight loss, Weight loss methods, Weight loss 
guidelines, Guidelines for weight loss, Guidelines for overweight and obesity. The 
populations consisted of; Weight loss in women, Obesity treatments for Hispanic, 
African Americans, Asian and Indian women. Years included in the literature search 
were from 2000 to present. Limiters included: Abstracts available, full text online, 
peer-reviewed, English language, humans, female, and adults 19 and older. The 
searches produced 820,000 articles. Of the articles, 210 were relevant and 57 were 
used in the development of this project. Article selection was determined by whether 
each article was evidence-based, peer-reviewed and could be applied to women. 
Guidelines for the algorithm were evaluated and selected according to the Agency for 
Healthcare Research and Quality’s guideline summaries. 
 A literature search revealed that the American Society of Bariatric Physicians, 
now called the Obesity Medicine Association, has an algorithm developed from 
evidence-based research (Obesity Medicine Association, 2017). This obesity 
algorithm is very comprehensive and details many options for treatment. A condensed 
version of this algorithm was developed by Horn (2013). The American Association 
of Clinical Endocrinologists (AACE) and the American College of Endocrinology 
(ACE) (Garvey et al., 2014) have an algorithm which includes more detailed staging 
of obesity and breaks down treatment and risk factors according to these stages. The 
American Diabetes Association also has an algorithm recommending therapies for 
weight loss, lifestyle choices and use of medications to treat type 2 diabetes in 
overweight and obese patients (American Diabetes Association, 2016).  
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 The general consensus of high-quality evidence in developing an algorithm 
includes the following elements falling under the Five “A”s; Ask, Assess, Advise, 
Assist and Arrange (Fitch et al., 2013; National Health and Medical Research 
Council, 2013). Many of the evidence-based studies concurred in regard to the five 
“A”s, however, they did not include the diagnosis and treatment of overweight and 
obesity specifically for women. 
 Baseline anthropometric measurements are considered BMI, waist-
circumference, weight and height. The 2013 AHA/ AAA/TOS Treatment Algorithm-
Chronic Disease Management Model for Primary Care of Patients with Overweight 
and Obesity further classifies obesity according to BMI; 30-34.9 (Class I), 35-39.9 
(Class II) and >40 (Class III) in (Jensen et al., 2013). The AACE and the ACE states 
in the 2014 “Advanced Framework for a New Diagnosis of Obesity as Chronic 
Disease” some specifics to clinical diagnostics and staging of obesity (Stages 0-2). 
The evidence strongly suggests the use of laboratory and other diagnostic tests such 
as blood pressure, fasting glucose, fasting lipid panel, creatinine along will hepatic 
transaminases and a full review of systems (Garvey et al., 2014). Other 
recommendations include fasting insulin, endocrine function along with a thorough 
history, family history, evaluation of risk factors and comorbid conditions.  
 Once the determination to lose weight has been made by the patient, the HCP 
should explain the risk factors involved and that a 5-10% weight reduction could 
significantly impact health (Fitch et al., 2013). The socio/social component, needs to 
be evaluated which includes the patient’s readiness to lose weight. Other factors to 
consider are realistic weight goal-setting, age and stage of life, cultural needs, 
ethnicity, economic and social circumstances, cognitive or physical disabilities and 
support system (National Institute for Health and Care Excellence [NICE], 2014) 
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 Physical activity was universally agreed upon in every study as an important 
element for weight loss. The evidence suggests some form of aerobic exercise > 150 
minutes per week. Approximately 200 to 300 minutes per week of higher levels of 
physical activity are recommended to maintain weight or minimize regaining weight 
(Jensen et al., 2013). 
Diet suggestions included estimating total energy needs according to the patient’s 
lifestyle (sedentary, low active, active, and very active) and adjusting caloric and 
nutritional intake accordingly. The Academy of Nutrition and Dietetics in the 2014 
Adult Weight Management Guideline details patient preferences, beliefs, attitudes 
and motivations as important components as well. The North American Association 
for the Study of Obesity (NAASO) and National Heart, Lung, and Blood Institute 
(NHLBI) have educational tools for reading labels, counting calories, meal planning, 
portion size and food substitution suggestions in the Practical Guide for 
Identification, Evaluation and Treatment of Overweight and Obesity in Adults (2000). 
This guideline contains an algorithm for treatment as well as follow up, which was 
seldom mentioned in the other studies. 
 According to recommendations from the Endocrine Society Clinical Practice 
Guideline pharmacological interventions are recommended for BMI > 27 with any 
comorbidity or a BMI > 30 (Apovian et al., 2015). This guideline also recommended, 
when possible, substituting current weight-causing medications for those that did not 
encourage weight gain. Multiple studies, including Yumuk et al. (2015) suggested 
when appropriate, treating with various drugs such as; Orlistat, Lorcaserin, 
Phentermine/ topiramate, Bupropione/ naltrexone or Liraglutide. 
 Monitoring the patient’s weight is recommended to evaluate if treatments are 
effective or need to be adjusted. Office visits approximately once a month for the first 
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three months, then every three months during the first year to assess the patient’s 
weight and measurements are recommend by Bays et al. (2013). While the Obesity 
Action Coalition (2017) suggests follow-up appointments once a month until target 
weight is achieved or a 5%-10% weight reduction. Most guidelines do not mention a 
specific timeline for follow-up appointments unless the patient has undergone 
bariatric surgery, but that they are encouraged. A calibrated scale at home, the use of 
phoning or emailing in their home weight, the use of mobile applications to monitor 
diet, weight and exercises are all proving to be effective as well to help patients stay 
focused on their goals (Allen, Stephens, Dennison Himmelfarb, Stewart, & Hauck, 
2013). 
 A collaborative treatment plan is imperative. Evaluation of the patient’s needs 
will be a priority to a successful weight loss program. Some patients will need 
treatment, in addition to their primary HCPs, from a registered dietician, psychiatrist, 
psychologist, physical therapist, personal trainer or social worker (Tsai & Wadden, 
2009). Patients with insufficient or no insurance coverage will have more challenges 
and may need help locating the assistance they require. Possible community resources 
to consider include exercise facilities, weight loss groups for support, transportation, 
access to quality food sources, and childcare (National Institute of Diabetes and 
Digestive and Kidney Diseases, 2017). Everyone involved needs to work 
collaboratively and synergistically to help the patient achieve the desired goal. 
 When current guidelines were examined, what was found were many ways to 
treat overweight and obesity, however gaps in the literature included the previously 
mentioned lack of testing and follow-up timeframes. Also, ethnocentric and gender 
specifity was insufficient, however if ethnicity was mentioned often the study was 
conducted in a European country. There is a lack of high quality studies for weight 
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maintenance and prevention for normo-weight/ BMI individuals, as well as a lack of 
qualitative research on the patient’s experiences and preferences with prevention, 
overweight and obesity interventions (Brauer et al., 2015). The “Clinical Practice 
Guidelines for Healthy Eating for Prevention and Treatment of Metabolic and 
Endocrine Diseases in Adults” outlined nutritional strategies for prevention and 
treatment for disease and conditions associated with overweight and obesity 
(Gonzalez-Campoy et al., 2013). Finally, according to Apovian et al., (2015) data 
regarding BMI gender variations is inadequate. 
 A simplified algorithm applicable and duplicable for everyday practice, 
inclusive for patients of all weight categories and stages is not available. The various 
obesity algorithms found were either very time consuming to evaluate or over 
generalized and not applicable in an easy to follow format. A practical application 
would be an algorithm designed from evidence-based guidelines, entailing a 
successive approach for each appointment. Clinical judgment should supersede the 
algorithm as needed per patient requirement.  
Purpose 
 This project is designed to help improve the care delivery system of how 
clinicians treat overweight and obesity. This is done through quality improvement of 
current practice in the women’s health setting by a weight loss algorithm with 
recommendations from obesity experts, evidence-based research, and guidelines. The 
algorithm allows a more standardized and duplicable approach for HCPs to treat this 
disease, directed specifically for women’s biological and emotional needs throughout 
this process, to ensure all aspects of obesity care are being addressed. The algorithm 
aims to inform practice about obesity and weight loss treatments, thus increasing 
clinician knowledge, treatment plans, and improved health outcomes for overweight 
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and obese female patients in a more efficient manner. 
 
Method 
 Implementation of this project began with a thorough literature search to 
identify best-practice guidelines for weight loss and any gaps pertaining to obesity 
treatment in women. Any existing weight loss algorithms were reviewed for clarity 
and clinical practicality. 
 This clinical project took place at two women’s health clinics located near St. 
Louis, MO. The patient population was 50 women, 19 years old and older. The 
women have a BMI of > 25 and a waist circumference of > 35 inches (88cm). 
Permission to audit patient information was granted by the office manager at the 
healthcare facility. All necessary HIPPA documentation was processed. The project 
was approved by the IRB of the University of Missouri- St. Louis (Appendix A). 
 A retrospective audit tool was developed to compare evidence-based 
recommendations for weight loss to the treatments provided to the patients. The tool 
included items from the following guidelines; American Heath Association/ 
American College of Cardiology/The Obesity Society (Jensen et al., 2013), Academy 
of Nutrition and Dietetics (2014), Canadian Task Force on Preventative Health Care 
(Brauer et al., 2015), National Health and Medical Research Counsel (2013), National 
Institute for Heath and Care Excellence (2014), the Institute for Clinical System 
Improvement (Fitch et al., 2013) and The Endocrine Society (Apovian et al., 2015). 
The audit tool displayed how often the recommended lab work, anthropometric 
measurements, medication, exercise and motivation were reviewed in the clinical 
setting for the initial and two subsequent appointments. The participant electronic 
health records (EHR) were reviewed, pertinent information was identified within the 
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audit tool and any discrepancies noted. This data was collected for a period of five 
months and the 50 patient charts were dated from 10/02/2014 through 01/06/2017. 
Data was extracted from each of the 50 charts and was compared for the frequency of 
patients whose care included the recommended items from the guidelines.  
Results 
 Fifty patient charts were audited for the first three consecutive visits for 71 
items over the course of five months. After examination of the data analysis tool 
some discrepancies and inconsistencies were noted. Research indicates that the 
following assessments and tests (see below) be performed to treat overweight and 
obesity. Most research did not state when exactly each of these should be done but 
that it is recommended for better diagnosis and assessment for overweight and 
obesity, however, according to Bays et al. (2013) weight loss patients should be 
followed-up at least quarterly.  
 The labs collected at the initial appointment and as necessary include; CBC, 
CMP, Lipid, TSH Reflex, Vit D levels, HgA1C, and urine analysis (Seger et al., 
2015). According to Steelman & Westman (2010) other forms of diagnostic testing 
such as ECG, cardiac stress testing, sleep studies, ultrasound of the liver and resting 
metabolic rate may indicated based on the results of clinical assessments and lab 
results. 
 An algorithm for a standardized approach was developed. The first three 
appointments follow a practical protocol allowing clinicians to address obesity with 
continuity of care. This standardization facilitates obesity treatment as other HCPs 
join the practice and are interested in treating this condition. The algorithm can be 
used as a template for current obesity practice providers and for new HCPs. 
 Some of the recommended items included in the algorithm are anthropometric 
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measurements such as: Body Mass index (BMI) to help define body fat based on 
height and weight. The definition of overweight according to BMI is 25-29.9, while 
obese is considered having a BMI of 30 or greater (U.S. Department of Health and 
Human Services, 2007). Other forms of measurement include; neck circumference, 
waist circumference, waist-to-hip ratio, bioelectric impedance, skinfold thickness, air-
displacement plethysmography, DEXA, dilution method, CT and MRI scan as 
suggested by Hu (2008).   
 After analyzing the results there were some differences between the guidelines 
and actual patient care noted. Under Patient History; cardiovascular, pulmonary, 
gastrointestinal, psycho-social/ cultural, endocrine and tobacco and illicit drug use 
were reviewed 100% of the time within the first three visits (See Table 1). 
Neurologic, medical/surgical conditions, medicine/ food allergies and current 
medications were reviewed at 98% of the appointments. Immune and eating disorders 
were examined at 10% of time while the patient’s integument at 6%. Family history 
was reviewed specifically for obesity and applicable familial diseases respectively 
94% and 100% of the time.  
 Nutritional history, including a review of the patient’s 24-hour diet and eating 
habits were documented 100% of the time within the first three appoints. While 
physical activity was stated at 80%.  
 Vital signs, height, weight and BMI were taken and reviewed at each of the 
three appointments 100% of the time. While the measurement of waist circumference 
was performed 4% of the time and neck circumference at 8% within the first three 
appointments. The comprehensive physical exam included nose, throat, neck 
examined 100% of the time. Examination of the lungs, heart, abdomen, 
musculoskeletal, and integument were performed 98% of the time.  
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 Recommended lab and bloodwork were taken at different portions of the time. 
Renal blood test was performed 98% of the time while liver enzymes and electrolytes 
96%. A fasting liver panel was completed 88% of the time, vitamin D 86%, thyroid 
stimulating hormone with reflex 84%. A complete blood count was ordered 80% of 
the time, hemoglobin A1C 46%, uric acid 6% and urine analysis and urine examine 
for microalbumin were not done at all. Other diagnostic testing was done as indicated; 
fasting insulin 62%, C-reactive protein, testosterone and other androgens 12%, 
cortisol 6%. While glucose tolerance, prolactin, follicle stimulating hormone and 
luteinizing hormone 2% of the time. Finally, estradiol, pregnancy test and iron studies 
were not documented as done.  
 The category relating physical activity was as follows; assessment of physical 
readiness 96%, assess mobility 100%, assess fitness level 96% of the time.  
 Behavior therapy review included looking at the patient’s triggers for 
overeating or eating the wrong types of foods 86% of the time. Assessment of the 
patient’s knowledge deficit of what to do to lose weight was performed within the 
first three appointments 94% of the time. A look at the patient’s stress and support 
system was examined at 92% of the appointments.  
 A review of the patient’s medications contributing to weight gain or difficulty 
losing weight were performed 25% of the time and the medications were adjusted or 
discontinued 20% of the time. It was noted that 48% of the time patients were started 
on metformin. As this study progressed, medications known to encourage weight loss 
were added. These specific medications were prescribed 76% of the time. Once added 
they were continued within the three visits 76% of the time. Sixty-two percent were 
changed to another weight loss drug or had dosing alterations, while 38% were 
discontinued all together.  
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 Finally, the use of electronic devices to assist in the weight loss process was 
listed as reviewed during 4% of the visits. The various devices measured caloric 
intake, physical activity, sleep schedules and some suggested recipes for the diets the 
patients were following. 
When clinicians at the project site were asked why they did not address weight loss or 
follow the recommended guidelines, lack of valuable clinical time was the main 
reason, forgetting certain assessments and not wanting to impose on support staff for 
extra anthropometric measurements were also identified as factors. Lastly, one of the 
clinicians stated she felt uncomfortable bringing up such a sensitive topic to 
overweight women especially since she was of a slender build. 
Discussion 
 In summary measurements such as vital signs, the assessment of mobility and 
the discussion of the patients 24-hour diet were performed at every visit. Other items 
such as the neck and waist circumference were done under 10% of the time. These 
results are also listed in Table 1 and display the wide range of inconsistencies within 
the three appointments. The evidence-based recommended guidelines were not 
consistently followed. 
 Each of the above measurements and assessments should be looked at and 
documented according to evidence-based guidelines (Steelman & Westman, 2010). It 
is important to follow the recommended guidelines because without adequate 
anthropometric measurements, monitoring the patient’s progress throughout treatment 
is difficult. For example, a neck circumference in women can help determine an 
obstructive sleep apnea risk (OSA) if > 16 inches. Kushida (2010), goes on to state 
that neck circumference is one of the most powerful predictors of OSA, which 
impacts the cardiovascular, neurological, endocrine systems.  
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 According to Moore and Cunningham (2012) the patient’s history is related to 
their stress level, dietary behaviors and risk for obesity which should be routinely 
examined.  The use of the 24-hour food recall survey to assess dietary intake and 
investigating the patient’s physical activity was recommend by Beechy, Galpern, 
Petrone, and Das (2012). 
 Bays et al. (2013) mention that a fasting lipid panel should be performed to 
evaluate cardiovascular risk, metabolic syndrome/ insulin resistance. Steelman & 
Westman (2010) also recommend each of the tests listed above as routine laboratory 
tests for weight loss assessment and treatment.  
 Research by Meriwether, Lee, Lafleur, and Wiseman (2008) states that 
readiness, mobility and fitness level pertaining to physical activity should be 
addressed. This would allow some insight into the patient abilities, preferences and 
inclination towards exercise. 
 Patient triggers, knowledge deficits, stress level and support systems are all 
things to consider. These behaviors are an important part of the weight loss 
assessment according to Jacob and Isaac (2012) and ought to be incorporated into 
these appointments.  
 For the patient’s medications, studies recommend reviewing and finding 
suitable alternatives if possible for medications known to increase body weight 
(Apovian et al., 2015). Bray (2013) suggests that using specific medications to help 
treat overweight and obesity can be beneficial because they enhance behaviorally-
induced weight loss. Kumar and Aronne (2015) mention that obesity is a chronic 
disease and should be treated with medication, if needed, to assist patients lose 
weight. These studies go on to list some of the current FDA approved weight loss 
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medication currently available. 
 Finally, monitoring weight, food intake and physical activity using mobile 
applications have proved to be effective according to Allen, Stephens, Dennison 
Himmelfarb, Stewart and Hauck (2013). The results of all the items in the chart audit 
can be found in Table 1.  
Development of Weight Loss Algorithm 
 To assist in closing the practice gaps for weight loss treatment and addressing 
the main reasons as to why evidence-based practice was not being more uniformly 
followed an algorithm was designed, for visits one (Appendix B), two (Appendix C), 
and three (Appendix D). A template for clinical assessment and treatment that could 
be used in the EHR system for the initial and two subsequent appointments was 
designed. Evidence-based criteria specifically for the obesity treatment was included 
in the algorithm. The template contains parameters recommend by guidelines to 
improve assessment and treatment of overweight and obesity. This tool has a 
sequential flow looking at History, Physical and treatment plans but also includes 
Nutrition, Physical Activity, Behavioral Therapy, Weight Loss Medications and 
Patient Goals. The clinician has the option to use this template as an algorithm to help 
make decisions regarding treatment plans. For a HCP familiar with obesity treatments 
the template would serve as a reminder to include specific assessments and to a new 
clinician it would serve as a decision-making algorithm of treatment choices.  
Patient Health History Form 
 The next portion of this project consisted of developing a Patient Evaluation 
Heath History Form (Appendix E). The patient could either download the form 
through email, if they have an electronic patient account set up, obtain through 
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standard mail or fill out when they arrive at the clinical setting. This would allow for 
better assessment and save clinical time. The form is based on the clinician algorithm 
while using simpler lay language and is designed to be able to transfer the 
information efficiently into the clinician assessment EHR. The ease of transferring 
this information will save the clinician time and avoid asking redundant or time-
consuming questions, thus increase efficacy.  
Obesity Parameters 
 Finally, a work-order was put into the women’s clinic IT department to 
include neck and waist circumference along with the standard BMI, height and 
weight measurements. This would serve as a reminder to get the necessary 
assessment measurements. The parameters of neck and waist circumferences were 
incorporated into the EHR Vital Signs and Measurements section. This involved 
putting in an input-request through the office manager and it went through the proper 
channels to the IT department. The extra measurements are considered a soft 
parameter, meaning they are optional without an alarm. According to the evidence 
previously cited, these measurements should be included for obesity treatment. 
Limitations 
 The limitations for this project consisted of finding three consecutive weight 
loss appointments. The appointments had to be for weight loss and not OB/GYN and 
there was some degree of no-show appointments as well. This resulted in the audit 
time spanning from 10/02/2014 through 01/06/2017; over that timeframe some of the 
practice assessments and charting had changed. The results showed the discrepancies 
of what assessments were not charted. In the process of completing the audit, data 
was sometimes found in sections of the EHR that were not consistent with where it 
should have been found so some data may have been missed. After observing many 
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weight loss appointments in this clinical setting, the clinician often reviewed more 
items and may have simply not documented all of them, thus the audit data does not 
reflect this. 
Implications and Future Direction 
 Implications for practice include utilizing this weight loss algorithm, patient 
health history forms and new measurement parameters to improve overweight and 
obese patient assessment and treatment. The trained obesity clinician and the new 
HCP interested in treating this disease will have an assessment and diagnostic tool to 
use accordingly. Finally, this algorithm will help close the gap between evidence-
based research and clinical practice for treating overweight and obesity.  
 The future direction consists of training support staff and other clinicians of 
new measurement parameters and assessment tools. Future projects could then 
evaluate the effectiveness of the use of evidence-based algorithm in management of 
overweight and obesity. A pilot study will then be done to evaluate improvement of 
the recommended guidelines being addressed and documented. 
Conclusion 
 Weight loss needs to be a multifaceted approach. Clinicians adhering to a 
best-practice algorithm developed from the evidence will allow congruency and 
continuity of care. There are numerous patient variables associated with losing 
weight. Removing HCP and assessment tool inconsistencies from practice will give 
overweight and obese women a greater opportunity to succeed at their weight loss 
goals. 
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       TABLE 1 
 
History:  
Patient History: cardiovascular, pulmonary, gastrointestinal, psycho-
social/ cultural, endocrine and tobacco and illicit drug use. 
100% 
Neurologic, medical/surgical conditions, medicine/ food allergies and 
current medications.  
98% 
Immune and eating disorders. 10% 
Integument 6% 
Family History: obesity  94%  
Applicable familial disease 100% 
Patient Nutritional History: patient’s 24-hour diet and eating habits  100% 
Patient Physical Activity:  Physical activity 80% 
Vitals/ Measurements   
Vital signs, height, weight and BMI  100% 
Waist circumference 4% 
Neck circumference  8% 
Physical exam: nose, throat, neck.  100% 
Lungs, heart, abdomen, musculoskeletal, and integument  98% 
Lab work & Diagnostic Testing: Renal blood test  98% 
Liver enzymes, electrolytes  96% 
Fasting liver panel  88% 
Vitamin D 86% 
TSH w/ Reflex 84% 
CBC 80% 
HgbA1c 46% 
Uric acid 6% 
Urine Analysis 0% 
Additional Testing as Indicated:  
Fasting Insulin 62% 
C-reactive protein & Testosterone and other androgens 12% 
Cortisol 6% 
Glucose tolerance, prolactin, follicle stimulating hormone and 
luteinizing hormone  
2% 
Activity   
Physical activity: readiness 96% 
Mobility 100% 
Fitness level 96% 
Behavior:  
Triggers or eating wrong kinds of food 86% 
Knowledge deficit 94% 
Stress and Support System 92% 
Medications:  
Contributing to weight gain/ Difficulty losing 25% 
Medications adjustments or discontinued 20% 
Started on Metformin 48% 
Weight loss medication prescribed 76% 
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Weight loss medication continued 76% 
Weight loss medication change (types or dosing) 62% 
Weight loss medication discontinued 38% 
Mobil Applications used for weight loss 4% 
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APPENDIX A 
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Telephone: 314-516-5899 
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DATE: January 21, 2017 
TO: Jennifer Williams 
FROM: University of Missouri-St. Louis IRB 
PROJECT TITLE: [991570-1] A Functional Algorithm for Weight Loss and Obesity 
Practice: 
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REFERENCE #: 
SUBMISSION TYPE: New Project 
ACTION: DETERMINATION OF EXEMPT STATUS 
DECISION DATE: January 21, 2017 
REVIEW CATEGORY: Exemption category # 4 
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above mentioned protocol for research involving human subjects and determined that 
the project qualifies for exemption from full committee review under Title 45 Code of 
Federal Regulations Part 46.101b. The time period for this approval expires one year 
from the date listed above. You must notify the University of Missouri- St. Louis IRB 
in advance of any proposed major changes in your approved protocol, e.g., addition 
of research sites or research instruments. You must file an annual report with the 
committee. This report must indicate the starting date of the project and the number 
of subjects to date from start of project, or since last annual report, whichever is more 
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Any consent or assent forms must be signed in duplicate and a copy provided to the 
subject. The principal investigator must retain the other copy of the signed consent 
form for at least three years following the completion of the research activity and they 
must be available for inspection if there is an official review of the UM-St. Louis 
human subjects research proceedings by the U.S. Department of Health and Human 
Services Office for Protection from Research Risks. 
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include your project title and reference number in all correspondence with this 
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WEIGHT LOSS ALGORITHM    35 
 
APPENDIX B 
Template for Assessment and Treatment for Overweight and Obesity 
Appointment #1 
 
 
INITIAL EXAM: 
Introduction, what can I do for you? May need to ask for permission to discuss body 
weight. 
So, I understand you are interested in learning about some ways to obtain your weight 
goals? 
Complaint: 
 
Past Medical History: 
(Positive responses in bold) 
Cardiovascular: Afib, CHF, HTN, PE, Stroke, Varicosities, Heart palpitations 
Pulmonary: Asthma, Dyspenia, OSA. 
Neurologic: Intracranial hypertension, nerve entrapment (carpel tunnel etc.), Seizure 
disorders 
Musculoskeletal: Altered center of gravity, Impaired balance, Immobility, Lower 
back pain, Myalgias, Osteoarthritis, Fibromyalgia, Accidents, Broken bones  
Endocrine: Acanthosis Nigricans, DM, Insulin resistance/ Metabolic Syndrome, 
Decreased HDL, Hyper lipids, Hyper triglycerides, 
Gastrointestinal: Cholelithitis, GERD, Glomerulopathy, Hernias, Nephrolithitis, 
urinary incontinence, pelvic prolaspe 
Integument: Carbuncles, Cellulitis, Bacterial or fungal skin fold infections, Skin tags, 
Stria distensae, Stasis pigmentation, hirsutism 
Psycho/ Social: Anxiety, Body image dissatisfaction, Depression, Diminished sex 
drive, Eating disorders, Experienced bullying, Feeling unmotivated, Hopelessness, 
Impaired intimacy and sexual relationships, PTSD, Work absenteeism or decreased 
work production 
Any Cancers: 
Other: 
GYN History: (Positive Responses in Bold) 
GYN: PCOS, infertility, Difficulty getting pregnant, HX of reproductive assistance, 
heavy, irregular, or painful periods, missed or not having periods, diabetes when 
pregnant, Preeclampsia, endometriosis, Adenomyosis 
Other: 
Past surgical History: 
Social History: 
Significant others:  Tobacco use: yes/ no, ETOH: yes/ no, Illicit drug use: yes/ no 
Employment:    Exercise: yes/ no 
Feels safe: yes/ no  Support at home: yes/ no  
Family History: 
Mother:  Father:  Sister:  Sister 2:  Brother:   
Brother 2:  Paternal Grandmother:  Paternal Grandfather:    
Maternal Grandmother: Maternal Grandfather: 
Allergies: Food:   Medication: 
Medications: (Review and bold weight-related medications: Beta-blockers, CCB, 
insulins, sulfonylureas, thiazolidinesediones, Meglitinides, glucocorticoids, estrogens, 
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Carbamazepine, Gabapentin, Valproate, TCAs, SSRIs, MAOIs, SNRIs, Lithium, 
Vigabatrin, Most Antipsychotics, some HAART, some Chemotherapies) 
List: 
Nutrition History: 
Timing:  Frequency: Who prepares food: Fast-food:  Restaurants: 
Meals and Snacks: 
24 Hour recall: Breakfast:  Lunch:  Dinner: Snacks: 
Weight History: (when at lowest/ highest) 
Behavior History: 
Triggers: Cravings: or nighttime eating,  binge eating,  emotional eating,  
Cultural/ familial/ community influences: 
Support System: 
Previous Diets:   
Physical Activity History: 
Current mobility/ fitness level: 
What kind: (frequency, intensity, time)   Success/ failure 
Motivation/ Readiness: 
Goals: (improve health, quality of life, improve body weight and composition) 
Barriers: 
Health Maintenance: 
PAP:    Mammogram:  Colonoscopy: 
Review of Systems: (Positive responses in bold) 
Constitutional: Denies significant weight changes, fever, chills, fatigue 
Psych: Denies feeling depressed, crying spells, anxiety, sleep disturbances, 
hopelessness, feeling guilty, unworthy, dislikes how clothing fits, forgetfulness, 
daytime sleepiness, stress, cognitive changes 
HEENT: Denies visual changes, headaches, seizures, sinus problems, sore throat, 
dental problems, deviated septum, 
Respiratory: Denies shortness of breath, cough, hemoptsis, wheezing, snoring, 
restless sleep or leg movements 
Cardiovascular: Denies chest pain, palpitations, swelling of legs 
Gastrointestinal: Denies fecal incontinence, incontinence of flatus, diarrhea, 
nausea/vomiting, constipation, bloody stools 
Genitourinary: Denies urinary incontinence, urinary urgency, dysuria, dyspareunia, 
vaginal dryness 
Breast: Denies breast masses, mastalgia, galactorrhea 
Endocrine: Denies dry skin, hair loss/growth, abnormal thirst, hot flashes 
Integumentary: Denies any rashes lesions, acne 
Objective Data: 
PHYSICAL EXAM: 
VS: BP:   P:  Temp:  R: 
WT:   HT:   BMI:   Waist/hip:  
Neck circumference: > 16 inches yes/ no ______inches/ cm 
General: Well nourished, age-appropriate looking female 
Anatomical paradox: apple or pear 
Neuro/Psych: Normal mood and affect A&O. 
HEENT: Normocephalic, atraumatic, 
Neck: supple, no lymphadenopathy, no thyromegaly, no tooth enamel erosion 
Tonsils Yes/ No Grade: 
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Heart: RRR, no murmurs/rubs/gallops 
Lungs: CTA x4 
Breast: no lumps or masses 
Abdomen: Soft, nontender, nondistended, no masses or hepatospenomegaly, no 
hernia noted 
Extremities: No clubbing, cyanosis, or edema. No varicosities 
Skin: Warm and dry without rash, lesions acne. No acanthosis nigricans, No 
intertrigo, venous stasis ulcers, stasis pigmentation, no stria, no Russell sign 
Pelvic: 
Laboratory Testing: 
CBC, CMP, Fasting Lipids, Liver enzymes, HgbA1c, THS/reflex, Insulin, Vitamin D 
levels, urine for microalbumin. 
Additional Testing: 
Hyperinsulinemia: Proinsulin, C-peptide, insulin 
Unexplained oligomenorrhea or amenorrhea: Prolactin, estradiol, FSH, LH, HCG 
PCOS, hirsutism, acne: testosterone, DHEA 
Elevated triglycerides: Apolipoprotein B or particle number 
Inflammation, Myalgias: C-reactive protein 
Fatigue, Anemia: Fe+ studies: Fe+, total iron building capacity, ferritin 
ASSESSMENT: 
DX: 
 
Patient Management: 
TREATMENT: 
POC: 
1. Nutrition: 
Carbs: (low carb: 50-150 /day, < 30 per 3-hour period, < 20 carbs/day) Fats: 
Increase healthy fats  Protein: 
2. Physical activity: 
Weight loss: (at least 150 minutes, preferably >300 minutes/ week of moderate or 150 
minutes/ week of intense)   Maintenance: (higher levels and intensity >200-
300 minutes/ week) 
3. Behavior therapy: 
(Ask, assist, advise, agree, arrange/assist). Motivation/ Goals: Barriers: 
Stress management:   Mobil Apps: 
4. Medication: 
(FDA approved anti-obesity medications for BMI > 30Kg/m or for overweight BMI > 
27 with Type 2 DM, dyslipidemia, or HTN) No improvement after 12 weeks, increase 
dosing or consider alternate drug. Please review dosing and side-effects. List initial 
dose and titration schedule. 
Cravings: Bupropion & Naltrexone/ CONTRAVE 
Hunger: (Lorcaserin/ BELVIQ, Phentermine & Topamax/ QSYMIA, 
Binge-eating: (VyVanse, Fluoxetine, topiramate, naltrexone) 
Night-eating: (behavior therapy) 
Diabetic: Liraglutide/ VICTOZA  
Combo: Liraglutide/ SAXENDA 
5. Referrals: 
(Behavioral health, psychiatrist, primary care, cardiologist, endocrinologist, Sleep 
medicine) 
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FU: 8-12 weeks 
Pt Education: 
Discussed with patient: 
Goals: Discussed most important goals/ motivators and possible barriers. SMART 
goals (specific, measurable, assignable, realistic, time-related) 
Nutrition: Discussed keeping food diary, reviewed basics of nutrition, reduce 
carbohydrates, increase healthy fats (almonds, avocados, cheeses etc.) and protein 
(fish, chicken, beef, pork). What is insulin resistance/ metabolic syndrome, PCOS, 
DM, menopause and how does it relate to obesity. 
Physical activity: Instructed pt to strive for at least 150 minutes, preferably > 300 
minutes/ week. Explained to keep moving for NEAT (Non-exercise activity 
thermogenesis) Take stairs not elevator etc. 
Keep daily activity logs. 
Behavior therapy: Discussed triggers and what to do when they occur. Patient has 
support system in place. Encouraged mobile app to motivate, track activity and food 
intake. 
Medication: Discussed how to take medication and potential side/effects 
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             APPENDIX C 
 
Template for Assessment and Treatment for Overweight and Obesity 
Appointment #2 
 
FOLLOW-UP EXAM: (8-12 weeks) 
  
Introduction: How are you doing? What are you enjoying or dislike about the weight 
loss program? 
Medical changes? 
Complaint: 
Allergies: Food:  Medication: 
(Positives in bold) 
Medications: (Review and bold weight-related medications: Beta-blockers, CCB, 
insulins, sulfonylureas, thiazolidinesediones, Meglitinides, glucocorticoids, estrogens, 
Carbamazepine, Gabapentin, Valproate, TCAs, SSRIs, MAOIs, SNRIs, Lithium, 
Vigabatrin, Most Antipsychotics, some HAART, some Chemotherapies) 
List: 
Nutrition: 
Timing: Frequency: Fast-food: Restaurants: 
Meals and Snacks: 
24 Hour recall: Breakfast:  Lunch:  Dinner: Snacks: 
Behavior Therapy: 
Triggers: Cravings: or nighttime eating, binge eating, emotional eating, 
Cultural/ familial/ community influences: 
Behavioral health: Yes/ No Psychiatry: Yes/ No   
Stress management, hobbies, self-care 
Assess motivation, reinforce/set new goals, review barriers  
Support System: 
Physical Activity: 
Current mobility/ fitness level: 
What kind: (frequency, intensity, time)   Success/ failure 
Motivation/ Readiness: 
Goals: (improve health, quality of life, improve body weight and composition) 
Barriers: 
Medication: (positive in bold). 
Cravings: Bupropion & Naltrexone/ CONTRAVE (dosing) 
Hunger: (Lorcaserin/ BELVIQ, Phentermine & Topamax/ QSYMIA, (dosing) 
Binge-eating: (VyVanse, Fluoxetine, topiramate, naltrexone) (dosing)  
Night-eating: (behavior therapy) 
Diabetic: Liraglutide/ VICTOZA (dosing) 
Combo: Liraglutide/ SAXENDA (dosing) 
Side Effects: 
Review of Systems: (Positive responses in bold) 
Constitutional: Denies significant weight changes, fever, chills, fatigue 
Psych: Denies feeling depressed, crying spells, anxiety, sleep disturbances, 
hopelessness, feeling guilty, unworthy, dislikes how clothing fits, forgetfulness, 
daytime sleepiness, stress, cognitive changes 
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HEENT: Denies visual changes, headaches, seizures, sinus problems, sore throat, 
dental problems, deviated septum, 
Respiratory: Denies shortness of breath, cough, hemoptsis, wheezing, snoring, 
restless sleep or leg movements 
Cardiovascular: Denies chest pain, palpitations, swelling of legs 
Gastrointestinal: Denies fecal incontinence, incontinence of flatus, diarrhea, 
nausea/vomiting, constipation, bloody stools 
Genitourinary: Denies urinary incontinence, urinary urgency, dysuria, dyspareunia, 
vaginal dryness 
Breast: Denies breast masses, mastalgia, galactorrhea 
Endocrine: Denies dry skin, hair loss/growth, abnormal thirst, hot flashes 
Integumentary: Denies any rashes lesions, acne  
Objective Data: 
Physical Exam: 
VS: BP:   P:  Temp:  R: 
WT:   HT:    BMI:    Waist/hip:  
Neck circumference: > 16 inches yes/ no ______inches/ cm 
General: Well nourished, age-appropriate looking female. 
Anatomical paradox: apple or pear  
Neuro/Psych: Normal mood and affect A&O. 
HEENT: Normocephalic, atraumatic, 
Neck: supple, no lymphadenopathy, no thyromegaly, no tooth enamel erosion 
Tonsils Yes/ No Grade: 
Heart: RRR, no murmurs/rubs/gallops 
Lungs: CTA x4 
Breast: no lumps or masses  
Abdomen: Soft, nontender, nondistended, no masses or hepatospenomegaly, no 
hernia noted 
Extremities: No clubbing, cyanosis, or edema. No varicosities 
Skin: Warm and dry without rash, lesions acne. No acanthosis nigricans, No 
intertrigo, venous stasis ulcers, stasis pigmentation, no stria, no Russell sign 
Pelvic: 
Laboratory Testing: 
Assessment: 
DX: 
 
Patient Management: 
TREATMENT: 
POC: 
1. Nutrition: 
 Carbs: (low carb: 50-150 /day, < 30 per 3-hour period, < 20 carbs/day) Fats: 
Increase healthy fats  Protein: 
2. Physical activity: 
Weight loss: (at least 150 minutes, preferably >300 minutes/ week of moderate or 150 
minutes/ week of intense) 
Maintenance: (higher levels of activity and intensity >200-300 minutes/ week) 
3. Behavior therapy: 
 (Ask, assist, advise, agree, arrange/assist). Motivation/ Goals: Barriers: 
Stress management:   Mobile Apps: Yes/ No 
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4. Medication/Dosing changes: 
5. Referrals: 
(Behavioral health, psychiatrist, primary care, cardiologist, endocrinologist, Sleep 
medicine) 
FU: 12 weeks 
Pt Education: 
Discussed with patient: 
Goals: Discussed most important goals/ motivators and possible barriers.  SMART 
goals (specific, measurable, assignable, realistic, time-related) 
Nutrition: Discussed keeping food diary, reviewed basics of nutrition, reduce 
carbohydrates, increase healthy fats (almonds, avocados, cheeses etc.) and protein 
(fish, chicken, beef, pork). What is insulin resistance/ metabolic syndrome, PCOS, 
DM, menopause and how does it relate to obesity. 
Physical activity: Instructed pt to strive for at least 150 minutes, preferably > 300 
minutes/ week. Explained to keep moving for NEAT (Non-exercise activity 
thermogenesis) Take stairs not elevator etc. 
Keep daily activity logs. 
Behavior therapy: Discussed triggers and what to do when they occur. Patient has 
support system in place. Encouraged mobile app to motivate, track activity and food 
intake. 
Medication: Discussed how to take medication and potential side/effects 
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            APPENDIX D 
 
Template for Assessment and Treatment for Overweight and Obesity 
Appointment #3 
 
FOLLOW-UP EXAM: (6 months) 
  
Introduction: How are you doing? What are you enjoying or dislike about the weight 
loss program? 
Medical changes? 
Complaint: 
Allergies: Food:  Medication: 
(Positive in bold) 
Medications: (Review and bold weight-related medications: Beta-blockers, CCB, 
insulins, sulfonylureas, thiazolidinesediones, Meglitinides, glucocorticoids, estrogens, 
Carbamazepine, Gabapentin, Valproate, TCAs, SSRIs, MAOIs, SNRIs, Lithium, 
Vigabatrin, Most Antipsychotics, some HAART, some Chemotherapies) 
List: 
Nutrition: 
Timing:  Frequency: Fast-food: Restaurants: 
Meals and Snacks: 
24 Hour recall: Breakfast: Lunch:  Dinner: Snacks: 
Behavior Therapy: 
Triggers: Cravings: or nighttime eating, binge eating, emotional eating, 
Cultural/ familial/ community influences: 
Behavioral health: Yes/ No Psychiatry: Yes/ No   
Stress management, hobbies, self-care 
Motivation, reinforce/set new goals, review barriers  
Support system:  
Physical Activity: 
Current mobility/ fitness level: 
What kind: (frequency, intensity, time)   Success/ failure 
Motivation/ Readiness: 
Goals: (improve health, quality of life, improve body weight and composition) 
Barriers: 
Medication: (Positive in Bold) 
Cravings: Bupropion & Naltrexone/ CONTRAVE (dosing) 
Hunger: (Lorcaserin/ BELVIQ, Phentermine & Topamax/ QSYMIA, (dosing) 
Binge-eating: (VyVanse, Fluoxetine, topiramate, naltrexone) (dosing) 
Night-eating: (behavior therapy) 
Diabetic: Liraglutide/ VICTOZA (dosing) 
Combo: Liraglutide/ SAXENDA (dosing) 
Side Effects: 
Review of Systems: (Positive responses in bold) 
Constitutional: Denies significant weight changes, fever, chills, fatigue 
Psych: Denies feeling depressed, crying spells, anxiety, sleep disturbances, 
hopelessness, feeling guilty, unworthy, dislikes how clothing fits, forgetfulness, 
daytime sleepiness, stress, cognitive changes 
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HEENT: Denies visual changes, headaches, seizures, sinus problems, sore throat, 
dental problems, deviated septum, 
Respiratory: Denies shortness of breath, cough, hemoptsis, wheezing, snoring, 
restless sleep or leg movements 
Cardiovascular: Denies chest pain, palpitations, swelling of legs 
Gastrointestinal: Denies fecal incontinence, incontinence of flatus, diarrhea, 
nausea/vomiting, constipation, bloody stools 
Genitourinary: Denies urinary incontinence, urinary urgency, dysuria, dyspareunia, 
vaginal dryness 
Breast: Denies breast masses, mastalgia, galactorrhea 
Endocrine: Denies dry skin, hair loss/growth, abnormal thirst, hot flashes 
Integumentary: Denies any rashes lesions, acne  
Objective Data: 
Physical Exam: 
VS: BP: P:  Temp:  R: 
WT:   HT:   BMI:   Waist/hip:  
Neck circumference: > 16 inches yes/ no ______inches/ cm 
General: Well nourished, age-appropriate looking female. 
Anatomical paradox: apple or pear 
Neuro/Psych: Normal mood and affect A&O.  
HEENT: Normocephalic, atraumatic, 
Neck: supple, no lymphadenopathy, no thyromegaly, no tooth enamel erosion 
Tonsils Yes/ No Grade: 
Heart: RRR, no murmurs/rubs/gallops 
Lungs: CTA x4 
Breast: no lumps or masses 
Abdomen: Soft, nontender, nondistended, no masses or hepatospenomegaly, no 
hernia noted 
Extremities: No clubbing, cyanosis, or edema. No varicosities 
Skin: Warm and dry without rash, lesions acne. No acanthosis nigricans, No 
intertrigo, venous stasis ulcers, stasis pigmentation, no stria, no Russell sign 
Pelvic: 
Laboratory Testing: (Optional) Lipids, HgA1c, Insulin, Vitamin D 
Assessment: 
DX: 
 
Patient Management: 
TREATMENT: 
POC: 
1. Nutrition: 
Carbs: (low carb: 50-150 /day, < 30 per 3-hour period, < 20 carbs/day) Fats: 
Increase healthy fats  Protein: 
2. Physical activity: 
Weight loss: (at least 150 minutes preferably >300 minutes/ week of moderate or 150 
minutes/ week of intense)   Maintenance: (higher levels and intensity > 
200-300 minutes/ week) 
3. Behavior therapy: 
 Motivation/ Goals:  Barriers:  Stress management:   
Mobile Apps: Yes/ No 
WEIGHT LOSS ALGORITHM    44 
 
4. Medication/Dosing changes: 
5. Referrals: 
(Behavioral health, psychiatrist, primary care, cardiologist, endocrinologist, Sleep 
medicine) 
FU: 12 weeks 
Pt Education: 
Discussed with patient: 
Goals: Discussed most important goals/ motivators and possible barriers.  SMART 
goals (specific, measurable, assignable, realistic, time-related) 
Nutrition: Discussed keeping food diary, reviewed basics of nutrition, reduce 
carbohydrates, increase healthy fats (almonds, avocados, cheeses etc.) and protein 
(fish, chicken, beef, pork). What is insulin resistance/ metabolic syndrome, PCOS, 
DM, menopause and how does it relate to obesity. 
Physical activity: Instructed pt to strive for at least150 minutes preferably >300 
minutes/ week. Explained to keep moving for NEAT (Non-exercise activity 
thermogenesis) Take stairs not elevator etc. 
Keep daily activity logs. 
Behavior therapy: Discussed triggers and what to do when they occur. Patient has 
support system in place. Encouraged mobile app to motivate, track activity and food 
intake. 
Medication: Discussed how to take medication and potential side/effects 
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APPENDIX E 
 
Health History 
 (To be Used with Current Facility Patient Health History Form) 
 
Name:        Date:   _________                    
Date of Birth:   Race/Ethnicity:     ___ 
 
What are your expectations from treatment? Please be specific.   ___ 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
Do you have any allergies? (Please list)  ____________________________________ 
_____________________________________________________________________ 
 
Medical History: (Please Circle) 
Cardiovascular: AFib, Congestive heart failure, High Blood Pressure, Pulmonary 
Embolism, Stroke, Varicose veins, Heart palpitations 
Pulmonary: Asthma, Difficulty breathing, Sleep Apnea, Ever been told you snore  
*Please fill out Epworth Sleepiness Scale Form 
Neurologic: High blood Pressure in the Brain, Nerve entrapment (carpel tunnel etc.), 
Seizure disorders 
Musculoskeletal: Altered center of gravity, Impaired balance, Immobility, Lower 
back pain, Myalgias, Osteoarthritis, Fibromyalgia, Accidents, Broken bones 
Endocrine: Acanthosis Nigricans, Diabetes, Insulin resistance/ Metabolic Syndrome, 
Decreased HDL (good cholesterol), High cholesterol, High triglycerides, Thyroid 
Disorders, Hashimotos Disease, Inflammation, Rheumatoid Disorders 
Gastrointestinal: Cholelithitis, GERD, Glomerulopathy, Hernias, Nephrolithitis, 
urinary incontinence, pelvic prolaspe 
Integument: Carbuncles, Cellulitis, Bacterial or fungal skin fold infections, Skin 
tags, Stretch marks, Discolored skin from poor circulation, Unwanted or excessive 
hair growth (facial etc.) 
Psycho/ Social: Tiredness, Anxiety, Body image dissatisfaction, Depression, 
Diminished sex drive, Eating disorders, Experienced bullying, Feeling unmotivated, 
Hopelessness, Impaired intimacy and sexual relationships, PTSD, Work absenteeism 
or decreased work production 
*Please fill out Patient Health Questionnaire (PHQ-9) 
Any Cancers: 
_________________________________________________________________ 
Anything else? 
_________________________________________________________________ 
 
GYN History: 
Number of pregnancies: ______ 
Birth Control: ______________ 
GYN: Any history of: PCOS, infertility, Difficulty getting pregnant, history of 
reproductive assistance, heavy, irregular, or painful periods, missed or not having 
periods, diabetes when pregnant, preeclampsia, endometriosis, adenomyosis 
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Other: 
_____________________________________________________________________ 
 
Past surgical History: 
_____________________________________________________________________ 
Serious Accident/ Injuries? 
_____________________________________________________________________ 
 
Social History: (Please Circle) 
Significant others (who):   
Tobacco use: yes/ no, ETOH: yes/ no, Illicit drug use: yes/ no 
Employment (where): 
Exercise: yes/ no 
Feels safe: yes/ no 
Support at home: yes/ no 
 
Family History: (Please Circle) 
 Any serious or weight-related diseases? 
Mother:  Father:  Sister:  Sister 2:  
Brother:  Brother 2: 
 Paternal Grandmother:  Paternal Grandfather:    
 Maternal Grandmother:   Maternal Grandfather: 
 
Nutritional History: (Please Circle) 
*Please fill out 24 -Hour Diet Recall Form 
Eat: Breakfast  Lunch   Dinner  Snacks 
 
Behavior History: (Please Circle) 
 Cravings   Yes No 
 Hunger   Yes No 
 Triggers   Yes No 
 Binge Eat   Yes No 
Night Eating   Yes No 
 Emotional Eating  Yes No 
Cook at Home   Yes No 
 Eat Fast-Food   Yes No 
 Eat at Restaurants  Yes No 
 Support System  Yes No 
History of Abuse  Yes No 
Ever tried to hurt yourself Yes No 
 
Physical Activity History: (Please Circle) 
Exercise   Yes No 
Work    Yes No 
 Goals    Yes No 
 Barriers   Yes No 
 
Health Maintenance: (Please Circle and Write in Date) 
 PAP  Mammogram  Colonoscopy 
